10X Health (USA) and REVIV Global (UK) have announced a strategic partnership with M42, a global health organisation driven by advanced technology, artificial intelligence and genomics, and headquartered in Abu Dhabi. Together, they will launch 10XREVIV — an innovative collaboration bringing a first-of-its-kind Precision Nutrition System to the Middle East.
10XREVIV marks an important step forward in personalised health optimisation. The initiative combines genetic profiling, blood biomarker assessment and nutritional insights enhanced by proprietary AI, delivering tailored precision health recommendations for individuals.
Central to this offering is the 10X Precision Nutrition System, a patented life sciences platform created by 10X Health’s biotechnology team over more than ten years of research and development. The system examines up to 20 million genetic variants with 99.97% accuracy and integrates these findings with bloodwork and lifestyle information to produce a secure, personalised health report exceeding 400 pages.
Based on these findings, the system delivers targeted, science-backed interventions, including:
- 10X Precision Supplements – genetically tailored micro-bead formulations for optimal bioavailability across 22 micronutrients.
- 10X Precision Weight Management – personalised carbohydrate and fat modulation aligned with metabolic and genetic markers.
- Precision IV Therapy – globally patented genetically informed IV protocols, offering bespoke micronutrient infusions delivered exclusively through approved and certified medical facilities.
Beyond the system’s launch, the partnership will also establish a Precision Longevity flagship clinic, undertake a randomized control trial evaluating the impact of IV nutrition on Type 2 Diabetes, and introduce a Precision Nutrition training curriculum to educate clinicians in translating genetic insights into clinical practice to improve outcomes and extend healthspan.
Brandon Dawson, Co-Founder, Chairman & CEO of 10X Health, said:
“Our mission at 10X Health is to revolutionise how people understand and optimise their own biology. Partnering with M42 and REVIV Global enables us to combine proprietary AI, genetic science, and clinical excellence to deliver personalised solutions that transform lives — and to do so at the heart of a region leading the future of healthcare.”
Albarah El Khani, Chief Operating Officer, Integrated Health Solutions platform at M42, added:
“This collaboration exemplifies M42’s vision to harness advanced science and technology to empower people to live healthier for longer. Through 10XREVIV, we’re integrating genetics, biomarkers, and precision nutrition into everyday care, positioning Abu Dhabi as a model for the future of longevity medicine.”
Sarah Lomas, CEO & Founder of REVIV Global, stated:
“With 10X Health and M42, we are pioneering a new era of precision health and longevity. The 10XREVIV initiative is the culmination of years of clinical expertise and technological innovation, bringing together AI, genetics, and practical application to empower individuals and advance modern wellness globally.”
Together, 10X Health, REVIV Global, and M42 combine biotechnology innovation, clinical depth, and AI-driven data science to set new global standards in precision health.
10X Precision Nutrition Systems powered by M42 set the standard in Human Optimization and Longevity globally.